Notogen Inc.

"The findings are supportive of NTG-101 as a means to impede disc degeneration, promote disc regeneration, halt inflammation, and suppress the expression of molecules secreted by discs that are known causes of pain. -Dr. Mark Erwin #biotech #regenerativemedicine

NTG-101: A Novel Molecular Therapy That Halts the Progression of Degenerative Disc Disease http://ow.ly/syH630mCpPg in Scientific Reports by Nature News and Comment Study in collaboration with University of Toronto University of Alberta University Health Network

Therapeutic Potential of NTG-101, a Single Dose Injectable Treatment for Degenerative Disc Disease, Demonstrated in Preclinical Large Animal Study Published in Nature Publishing Group's Scientific Reports http://ow.ly/9c3v30mCrKG

We're pleased to announce the launch of our new website. Visit us at http://www.notogen.com #biotech #startup #regenerativemedicine